Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001183740-22-000180
Filing Date
2022-11-16
Accepted
2022-11-16 13:36:37
Documents
1
Effectiveness Date
2022-11-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10154
  Complete submission text file 0001183740-22-000180.txt   11477
Mailing Address 500 CUMMINGS CTR., SUITE 4550 BEVERLY MA 01915
Business Address 500 CUMMINGS CTR., SUITE 4550 BEVERLY MA 01915 800-215-1824
LexaGene Holdings Inc. (Filer) CIK: 0001450416 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0228
Type: D | Act: 33 | File No.: 021-464970 | Film No.: 221394495
SIC: 3841 Surgical & Medical Instruments & Apparatus